| HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells SE Woodfield, BJ Mistretta, RH Patel, AM Ibarra, KE Fisher, SF Sarabia, ... Biology Open 11 (9), bio058973, 2022 | 3 | 2022 |
| A Novel Treatment Strategy Utilizing Panobinostat for High-Risk and Treatment-Refractory Hepatoblastoma AF Espinoza, RH Patel, KR Patel, AA Badachhape, R Whitlock, ... Journal of Hepatology, 2024 | 2 | 2024 |
| Romidepsin therapy results in p53 mediated apoptosis in hepatoblastoma AF Espinoza, R Whitlock, R Srivastava, R Patel, S Govindu, A Shah, ... Cancer Research 82 (12_Supplement), 1825-1825, 2022 | 1 | 2022 |
| An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer AF Espinoza, P Kureti, RH Patel, SL Do, SR Govindu, BW Armbruster, ... Hepatology Communications 8 (6), e0435, 2024 | | 2024 |
| Abstract A008: An indocyanine green-based liquid biopsy test for circulating tumor cells for hepatoblastoma AF Espinoza, RH Patel, BW Armbruster, P Kureti, SR Govindu, ... Cancer Research 83 (2_Supplement_2), A008-A008, 2023 | | 2023 |
| Surgical Resection for Pediatric Synovial Sarcoma: What Margin Is Adequate? AF Espinoza, H Todd, E Castro, A Shah, S Govindu, SA Vasudevan Journal of the American College of Surgeons 235 (5), S192, 2022 | | 2022 |
| Abstract PO013: Patient-derived xenograft mouse models of hepatoblastoma for a personalized medicine pipeline SE Woodfield, RH Patel, AF Espinoza, RS Whitlock, J Epps, ... Clinical Cancer Research 28 (17_Supplement), PO013-PO013, 2022 | | 2022 |
